Clin2
NCT07603544Possibly a fitRecruiting

Hair Loss Study: Understanding Male Pattern Baldness

Androgenetic Alopecia (AGA)

Part of Skin clinical trials.

This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
12 people
Ages
20 years to 65 years
Study type
Observational

Who can take part

  • You are a male aged 25–30 or 60–65 years old
  • You have moderate hair loss (Hamilton-Norwood Stage III, meaning hair loss on the crown and front)
  • You have not used hair loss medications (like minoxidil or finasteride) or hormonal drugs in the last 6 months
  • You have not had chemical treatments like perms or dyes on your scalp in the last 6 months
  • You do not have other scalp conditions (psoriasis, dermatitis, infections) or other types of hair loss
  • You do not have serious health conditions like heart disease, immune disorders, cancer, blood clotting problems, or keloids

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07327359Recruiting· Phase 1/Phase 2
Study of OLX72021 for male pattern baldness

This trial tests an investigational drug called OLX72021 for male pattern hair loss (androgenetic alopecia). It aims to see if the drug is safe and effective in healthy men with mild to moderate hair loss.

Camberwell, Victoria
NCT07317544Recruiting· Phase 1/Phase 2
Study of a new hair loss treatment in healthy adults

This trial tests a new medication called ABS-201 for hair loss. It will first see if the medicine is safe in healthy people, then test if it helps those with male or female pattern baldness.

Sydney, New South Wales
NCT06622824Not yet recruiting· Phase 2/Phase 3
KX-826 scalp solution for male pattern baldness

This trial tests a once-daily scalp solution called KX-826 to help men with typical male pattern baldness grow hair and slow hair loss. It compares the active solution to a placebo (no active ingredient) to see if it works and is safe.

Beijing
NCT06764329Enrolling by invitation· Phase 1/Phase 2
Stem cell therapy for male hair loss

This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.

Rawalpindi
NCT07529977Not yet recruiting· Phase 3
Oral Minoxidil for Male Hair Loss Treatment

This trial tests a new oral (pill) form of minoxidil to help regrow hair in men with male-pattern baldness. Minoxidil is a known hair-growth medication, and this study evaluates whether taking it as a pill works safely and effectively.

NCT07693244Recruiting· Phase 2
Exosome therapy for male pattern baldness

This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.

Beijing

Hear when a new Androgenetic Alopecia (AGA) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.